Drug class
Non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist; anti-gonadotropin
Mechanism of action
Competitively binds pituitary GnRH receptors and inhibits endogenous GnRH signalling, reducing LH and FSH secretion and producing dose-dependent suppression of ovarian oestradiol and progesterone.
General use cases
- Treatment of moderate-to-severe symptoms associated with uterine fibroids in adult women of reproductive age, under the applicable product authorisation.
- Treatment of endometriosis-associated symptoms where authorised by the relevant product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
